LEADER 04030nam 22005055 450 001 9910253874503321 005 20200704092502.0 010 $a3-319-27935-1 024 7 $a10.1007/978-3-319-27935-0 035 $a(CKB)3710000000734925 035 $a(EBL)4573582 035 $a(DE-He213)978-3-319-27935-0 035 $a(MiAaPQ)EBC4573582 035 $a(PPN)194375773 035 $a(EXLCZ)993710000000734925 100 $a20160629d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Microbiology, Infectious Diseases and Public Health $eVolume 2 /$fedited by Gianfranco Donelli 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (135 p.) 225 1 $aAdvances in Microbiology, Infectious Diseases and Public Health,$x2365-2675 ;$v901 300 $aIncludes index. 311 $a3-319-27934-3 327 $aOverview of the antimicrobial activity of 19 essential oils -- Refractory Trichophyton rubrum infections in Turin, Italy: a problem still present -- Antioxidant hydroxytyrosol-based polyacrylate with antimicrobial and antiadhesive activity versus Staphylococcus epidermidis -- The role of human Herpesvirus 8 in diabetes mellitus type 2: state of the art and a medical hypothesis -- Prevalence of Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae based on data collected by a network of clinical microbiology laboratories, in Italy -- ?-defensins: work in progress -- Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy -- Carbapenem-resistant Klebsiella pneumoniae: results of a laboratory surveillance program in an Italian General Hospital (August 2014-January 2015) -- A snapshot of drug-resistant M. tuberculosis strains in Croatia -- Quorum quenching strategy targeting gram-positive pathogenic bacteria. 330 $aThis Series will provide microbiologists, hygienists, epidemiologists and infectious diseases specialists with well-chosen contributed volumes containing updated information in the areas of basic and applied microbiology involving relevant issues for public health, including bacterial, fungal and parasitic infections, zoonoses and anthropozoonoses, environmental and food microbiology. The increasing threat of the multidrug-resistant microorganisms and the related host immune response, the new strategies for the treatment of biofilm-based, acute and chronic microbial infections, as well as the development of new vaccines and more efficacious antimicrobial drugs to prevent and treat human and animal infections will be also reviewed in this series in the light of the most recent achievements in these fields. Special attention will be devoted to the fast diffusion worldwide of the new findings of the most advanced translational researches carried out in the different fields of microbiological sciences, with the aim to promote a prompt validation and transfer at clinical level of the most promising experimental results. 410 0$aAdvances in Microbiology, Infectious Diseases and Public Health,$x2365-2675 ;$v901 606 $aMicrobiology 606 $aMedical microbiology 606 $aMicrobiology$3https://scigraph.springernature.com/ontologies/product-market-codes/L23004 606 $aMedical Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B16003 615 0$aMicrobiology. 615 0$aMedical microbiology. 615 14$aMicrobiology. 615 24$aMedical Microbiology. 676 $a570 702 $aDonelli$b Gianfranco$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910253874503321 996 $aAdvances in microbiology, infectious diseases and public health$91901317 997 $aUNINA